David Jollow to Chemical and Drug Induced Liver Injury
This is a "connection" page, showing publications David Jollow has written about Chemical and Drug Induced Liver Injury.
Connection Strength
0.736
-
Effects of sulfur-amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats. Toxicol Appl Pharmacol. 1989 Nov; 101(2):356-69.
Score: 0.080
-
Effect of glucose and gluconeogenic substrates on fasting-induced suppression of acetaminophen glucuronidation in the rat. Biochem Pharmacol. 1989 Jan 15; 38(2):289-97.
Score: 0.076
-
Relationship between sulfotransferase activity and susceptibility to acetaminophen-induced liver necrosis in the hamster. Drug Metab Dispos. 1987 Mar-Apr; 15(2):143-50.
Score: 0.066
-
Anomalous susceptibility of the fasted hamster to acetaminophen hepatotoxicity. Biochem Pharmacol. 1986 Mar 01; 35(5):817-25.
Score: 0.062
-
Strain differences in susceptibility of normal and diabetic rats to acetaminophen hepatotoxicity. Biochem Pharmacol. 1986 Feb 15; 35(4):687-95.
Score: 0.062
-
Effect of L-ascorbic acid on acetaminophen-induced hepatotoxicity and covalent binding in hamsters. Evidence that in vitro covalent binding differs from that in vivo. Drug Metab Dispos. 1984 May-Jun; 12(3):271-9.
Score: 0.055
-
Mechanism of ketone-induced protection from acetaminophen hepatotoxicity in the rat. Drug Metab Dispos. 1983 Sep-Oct; 11(5):451-7.
Score: 0.052
-
Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. J Pharmacol Exp Ther. 1982 Mar; 220(3):504-13.
Score: 0.047
-
Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite. J Pharmacol Exp Ther. 1976 Oct; 199(1):41-52.
Score: 0.032
-
Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest. 1975 Aug; 68(2):181-90.
Score: 0.030
-
Macrophage enhancement of galactosamine hepatotoxicity using a rat hepatocyte culture system. Res Commun Mol Pathol Pharmacol. 1995 Jun; 88(3):327-38.
Score: 0.029
-
Hepatic necrosis caused by furosemide. Nature. 1974 Oct 11; 251(5475):508-11.
Score: 0.028
-
Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974; 11(3):151-69.
Score: 0.027
-
Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther. 1973 Oct; 187(1):195-202.
Score: 0.026
-
Acetaminophen overdosage. J S C Med Assoc. 1977 Nov; 73(11):474-80.
Score: 0.009
-
Biochemical changes after hepatic injury from toxic doses of acetaminophen or furosemide. Pharmacology. 1976; 14(3):205-17.
Score: 0.008
-
Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther. 1974 Oct; 16(4):676-84.
Score: 0.007
-
Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology. 1974; 12(3):129-43.
Score: 0.007
-
Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther. 1973 Oct; 187(1):203-10.
Score: 0.007
-
Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther. 1973 Oct; 187(1):185-94.
Score: 0.007
-
Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 1973 Oct; 187(1):211-7.
Score: 0.007
-
Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J Pharmacol Exp Ther. 1973 Oct; 187(1):218-27.
Score: 0.007
-
Diminished serum Gc (vitamin D-binding protein) levels and increased Gc:G-actin complexes in a hamster model of fulminant hepatic necrosis. Hepatology. 1987 Sep-Oct; 7(5):825-30.
Score: 0.004
-
Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci. 1974 Jun 01; 14(11):2099-109.
Score: 0.002
-
Drug metabolism as a cause of drug toxicity. Drug Metab Dispos. 1973 Jan-Feb; 1(1):418-23.
Score: 0.002